ReviewMolecular pharmaceutics

Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Jeff L Staudinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.